| Microalbuminuria. | |
| | |
MedLine Citation:
|
PMID: 15702624 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
The capacity of microalbuminuria to predict an increased cardiovascular and renal risk is well established in diabetic patients, as well as in essential hypertensive patients and in general population. Detection of microalbuminuria could then be relevant to select specific therapeutic strategies for reducing or preventing cardiovascular events in patients with essential hypertension. Microalbuminuria is detectable in almost 40% of the population with established hypertension, particularly in those patients not controlled satisfactorily with medical therapy. Albuminuria may represent a marker of renal damage and cardiovascular risk in essential hypertension. Microalbuminuria seems to represent a simple and reproducible method to better define cardiovascular risk profile in the hypertensive patient and to stratify the prognosis in relation to renal and cardiovascular risk. ACE-inhibitors and more recently angiotensin II receptor antagonists seem to exhibit a more market capacity to reduce microalbuminuria in patients with essential hypertension or diabetes mellitus. Determination of this parameter in daily clinical practice could facilitate the stratification of risk as well as the choice of therapy in essential hypertensive patients. |
| | |
Authors:
|
J Segura; L M Ruilope; J L Rodicio |
Related Documents
:
|
8541174 - Appetite suppressants and primary pulmonary hypertension in the united kingdom. 11498654 - The beta blockers: are they as protective in hypertension as in other cardiovascular co... 10321824 - Radionuclide renography: a personal approach. 9707624 - A genetic defect resulting in mild low-renin hypertension. 3728314 - Hemodynamic and electrophysiologic results of the senning procedure for transposition o... 6654634 - Aldolase and adenosine deaminase activity in lymphocytes of patients with glomeruloneph... |
Publication Detail:
|
Type: Journal Article; Review |
Journal Detail:
|
Title: Clinical and experimental hypertension (New York, N.Y. : 1993) Volume: 26 ISSN: 1064-1963 ISO Abbreviation: Clin. Exp. Hypertens. Publication Date: 2004 Oct-Nov |
Date Detail:
|
Created Date: 2005-02-10 Completed Date: 2005-04-21 Revised Date: - |
Medline Journal Info:
|
Nlm Unique ID: 9305929 Medline TA: Clin Exp Hypertens Country: United States |
Other Details:
|
Languages: eng Pagination: 701-7 Citation Subset: IM |
Affiliation:
|
Nephrology Department, Hospital 12 de Octubre, Madrid, Spain. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Albuminuria
/
epidemiology* Antihypertensive Agents / therapeutic use Diabetic Nephropathies / epidemiology* Humans Hypertension, Renal / drug therapy, epidemiology* Risk Factors |
| Chemical | |
Reg. No./Substance:
|
0/Antihypertensive Agents |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Arterial stiffness: pathophysiology and clinical impact.
Next Document: Comparison of various blood pressure lowering treatments on the primary prevention of cardiovascular...